PATENT CLAIM ANALYSIS

Application Number: 15986727
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "476000"]

Abstract:
In an embodiment of the invention, a composition for treating a cell population comprises an Affinity Medicant Conjugate (AMC). The medicant moiety can be a toxin including an acylfulvene or a drug moiety. The affinity moiety can be an antibody, a binding protein, a steroid, a lipid, a growth factor, a protein, a peptide or non peptidic. The affinity moiety can be covalently bound to the medicant via a linker. Novel linkers that can be directed to cysteine, arginine or lysine residues based on solution pH allow greater flexibility in preserving and/or generating specific epitopes in the AMC.

Claim (Index 4):
The compound of  claim 2 , where \u2014X\u2014\u2550C(\u2550O)O\u2014 such that R 6  is covalently linked to the oxygen of X to form an ester bond.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 93.0
- Lexical Diversity: 1.66176
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15201301', '14684218', '14875476', '13397205', '11342937']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8374873246189284
- 35 USC 102 Novelty (BERT): 0.5938971386421099
- Combined Prediction Score: 0.8131283060212465
- Mean Citation Score: 491.007214
- Max Citation Score: 758.3846
- Similarity Product: 412.56386660900114

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test